InvestorsHub Logo

seve333

09/26/23 2:03 PM

#415906 RE: Jasbg #415904

But the 'real news' - on Brave - Mitigate - possible BO negotiations (interested BPs) - were not there - which the SP 'not reacting' indicates all to well.
------------------------

Like you said no news on the things we really need to get the SP moving. Looks like we may be setting up to close at another record low and we cannot continue to do that day after day or we will be at .50 cents soon. They need to figure out a way to stop the bleeding pretty fast here imo or who know how low she can go.

couldbebetter

09/26/23 2:12 PM

#415907 RE: Jasbg #415904

For now all small Bios are getting slammed down! As strongly as I feel
that only a BP will be able to optimize sales of Vascepa, for now the strategy
is to GIA and/or partner to build up revenues. If Denner plans to sell the company
my guess is he will bring up Sarissa's stake closer to 20%. Before any reasonable
BO can be announced he would have to get the share price up to a much higher
level. Meanwhile, we wait to see what can be salvaged from the US, how many
more countries in Europe AMRN can get for reimbursement, and, see what China
may bring. Of course we all hope that Denner will bring in more institutional ownership.
Watching this play out would be much more fun if the stock price were moving up!